Straits Times Index
3,201.89 +10.73 (+0.34%) S&P 500
4,088.85 +80.84 (+2.02%) Dow
32,654.59 +431.17 (+1.34%) Nasdaq
11,984.52 +321.73 (+2.76%) BTC-USD
30,481.63 +479.87 (+1.60%) CMC Crypto 200
677.94 +435.26 (+179.36%)
Biora Therapeutics, Inc. (PROG)
| Previous close | 0.9163 |
| Open | 0.9005 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 1400 |
| Day's range | 0.8400 - 0.9200 |
| 52-week range | 0.6301 - 6.2000 |
| Volume | |
| Avg. volume | 6,627,567 |
| Market cap | 162.924M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Why Shares of Progenity Are Down More Than 11% on Wednesday
Progenity (NASDAQ: PROG), a biotech company and a meme stock favorite, saw its shares decline more than 11% on Wednesday. Overall, Progenity stock is down more than 47% this year. The markets don't like uncertainty, and that's one reason Progenity has trended downward.
- Motley Fool
Why Progenity Stock Is Up More Than 34% Tuesday
Shares of Progenity (NASDAQ: PROG) were up more than 34% on Tuesday. At the time of its initial public offering in 2020, the biotech company went for $13 a share, and the stock has been highly volatile because it is a retail investor favorite. It is the second time in less than a month that Progenity has taken off on a short-squeeze-fueled frenzy.
- Zacks
Progenity, Inc. (PROG) Reports Q3 Loss, Lags Revenue Estimates
Progenity, Inc. (PROG) delivered earnings and revenue surprises of 19.15% and -98.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
